A copper-lowering strategy attenuates amyloid pathology in a transgenic mouse model of Alzheimer's disease

Joseph Quinn, Christopher J. Harris, Katherine E. Cobb, Christopher Domes, Martina Ralle, George Brewer, Teri L. Wadsworth

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

There is increasing evidence for the crucial role of metals in the pathology of Alzheimer's disease. Both the aggregation and neurotoxicity of amyloid-β are dependent on the presence of copper. This study investigated the ability of the copper-complexing drug tetrathiomolybdate to reduce amyloid-β pathology and spatial memory impairment in both a prevention and a treatment paradigm in the Tg2576 mouse model of Alzheimer's disease. Tetrathiomolybdate treatment lowered brain copper and reduced amyloid-β levels in the prevention paradigm, but not in the treatment paradigm. Our data suggests that controlled lowering of systemic copper may achieve anti-amyloid effects if initiated early in the disease process.

Original languageEnglish (US)
Pages (from-to)903-914
Number of pages12
JournalJournal of Alzheimer's Disease
Volume21
Issue number3
DOIs
StatePublished - 2010

Fingerprint

Amyloid
Transgenic Mice
Copper
Alzheimer Disease
Pathology
Aptitude
Metals
Brain
Pharmaceutical Preparations
tetrathiomolybdate

Keywords

  • Alzheimer's disease
  • amyloid
  • copper
  • tetrathiomolybdate
  • Tg2576

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

A copper-lowering strategy attenuates amyloid pathology in a transgenic mouse model of Alzheimer's disease. / Quinn, Joseph; Harris, Christopher J.; Cobb, Katherine E.; Domes, Christopher; Ralle, Martina; Brewer, George; Wadsworth, Teri L.

In: Journal of Alzheimer's Disease, Vol. 21, No. 3, 2010, p. 903-914.

Research output: Contribution to journalArticle

Quinn, Joseph ; Harris, Christopher J. ; Cobb, Katherine E. ; Domes, Christopher ; Ralle, Martina ; Brewer, George ; Wadsworth, Teri L. / A copper-lowering strategy attenuates amyloid pathology in a transgenic mouse model of Alzheimer's disease. In: Journal of Alzheimer's Disease. 2010 ; Vol. 21, No. 3. pp. 903-914.
@article{07b36e19689d4ae695682026d6688c98,
title = "A copper-lowering strategy attenuates amyloid pathology in a transgenic mouse model of Alzheimer's disease",
abstract = "There is increasing evidence for the crucial role of metals in the pathology of Alzheimer's disease. Both the aggregation and neurotoxicity of amyloid-β are dependent on the presence of copper. This study investigated the ability of the copper-complexing drug tetrathiomolybdate to reduce amyloid-β pathology and spatial memory impairment in both a prevention and a treatment paradigm in the Tg2576 mouse model of Alzheimer's disease. Tetrathiomolybdate treatment lowered brain copper and reduced amyloid-β levels in the prevention paradigm, but not in the treatment paradigm. Our data suggests that controlled lowering of systemic copper may achieve anti-amyloid effects if initiated early in the disease process.",
keywords = "Alzheimer's disease, amyloid, copper, tetrathiomolybdate, Tg2576",
author = "Joseph Quinn and Harris, {Christopher J.} and Cobb, {Katherine E.} and Christopher Domes and Martina Ralle and George Brewer and Wadsworth, {Teri L.}",
year = "2010",
doi = "10.3233/JAD-2010-100408",
language = "English (US)",
volume = "21",
pages = "903--914",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - A copper-lowering strategy attenuates amyloid pathology in a transgenic mouse model of Alzheimer's disease

AU - Quinn, Joseph

AU - Harris, Christopher J.

AU - Cobb, Katherine E.

AU - Domes, Christopher

AU - Ralle, Martina

AU - Brewer, George

AU - Wadsworth, Teri L.

PY - 2010

Y1 - 2010

N2 - There is increasing evidence for the crucial role of metals in the pathology of Alzheimer's disease. Both the aggregation and neurotoxicity of amyloid-β are dependent on the presence of copper. This study investigated the ability of the copper-complexing drug tetrathiomolybdate to reduce amyloid-β pathology and spatial memory impairment in both a prevention and a treatment paradigm in the Tg2576 mouse model of Alzheimer's disease. Tetrathiomolybdate treatment lowered brain copper and reduced amyloid-β levels in the prevention paradigm, but not in the treatment paradigm. Our data suggests that controlled lowering of systemic copper may achieve anti-amyloid effects if initiated early in the disease process.

AB - There is increasing evidence for the crucial role of metals in the pathology of Alzheimer's disease. Both the aggregation and neurotoxicity of amyloid-β are dependent on the presence of copper. This study investigated the ability of the copper-complexing drug tetrathiomolybdate to reduce amyloid-β pathology and spatial memory impairment in both a prevention and a treatment paradigm in the Tg2576 mouse model of Alzheimer's disease. Tetrathiomolybdate treatment lowered brain copper and reduced amyloid-β levels in the prevention paradigm, but not in the treatment paradigm. Our data suggests that controlled lowering of systemic copper may achieve anti-amyloid effects if initiated early in the disease process.

KW - Alzheimer's disease

KW - amyloid

KW - copper

KW - tetrathiomolybdate

KW - Tg2576

UR - http://www.scopus.com/inward/record.url?scp=77957257626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957257626&partnerID=8YFLogxK

U2 - 10.3233/JAD-2010-100408

DO - 10.3233/JAD-2010-100408

M3 - Article

C2 - 20693639

AN - SCOPUS:77957257626

VL - 21

SP - 903

EP - 914

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 3

ER -